Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:51 pm Sale | 13G | CIDARA THERAPEUTICS INC CDTX | Nantahala Capital Management LLC | 1,546,745 1.7% | -2,820,719 (-64.58%) | View |
| 2024-02-14 10:18 am Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | BIOTECHNOLOGY VALUE FUND L P | 9,275,527 9.99% | 2,414,400 (+35.19%) | View |
| 2024-02-14 10:02 am Sale | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management L.P. | 1,250,228 1.4% | -2,617,778 (-67.68%) | View |
| 2023-02-14 4:58 pm Sale | 13G | CIDARA THERAPEUTICS INC CDTX | Nantahala Capital Management LLC | 4,367,464 6.1% | -902,994 (-17.13%) | View |
| 2023-02-14 4:23 pm Sale | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management L.P. | 3,868,006 5.4% | -450,034 (-10.42%) | View |
| 2022-02-15 1:09 pm Sale | 13G | CIDARA THERAPEUTICS INC CDTX | LYTTON LAURENCE W | 1,708,328 2.5% | -1,632,072 (-48.86%) | View |
| 2022-02-14 4:48 pm Sale | 13G | CIDARA THERAPEUTICS INC CDTX | Omega Fund V L.P. | 1,249,999 1.8% | -2,005,249 (-61.60%) | View |
| 2022-02-14 4:41 pm Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management L.P. | 4,318,040 6.5% | 118,040 (+2.81%) | View |
| 2022-02-14 08:30 am Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | Nantahala Capital Management LLC | 5,270,458 7.9% | 5,270,458 (New Position) | View |
| 2022-02-11 4:48 pm Sale | 13G | CIDARA THERAPEUTICS INC CDTX | BB BIOTECH AG | 0 0% | -2,822,495 (Position Closed) | View |
| 2021-12-16 5:16 pm Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | BIOTECHNOLOGY VALUE FUND L P | 6,861,127 10.3% | 2,399,633 (+53.79%) | View |
| 2021-10-14 5:12 pm Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management L.P. | 4,200,000 6.3% | 4,200,000 (New Position) | View |
| 2021-08-11 7:27 pm Sale | 13D | CIDARA THERAPEUTICS INC CDTX | INTERWEST PARTNERS X LP | 903,739 1.9% | -453,074 (-33.39%) | View |
| 2021-03-05 7:26 pm Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | LYTTON LAURENCE W | 3,340,400 7% | 613,328 (+22.49%) | View |
| 2021-03-05 4:55 pm Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | LYTTON LAURENCE W | 2,727,072 5.7% | 2,727,072 (New Position) | View |
| 2021-02-16 11:39 am Sale | 13G | CIDARA THERAPEUTICS INC CDTX | 5AM VENTURES III L.P. | 2,006,511 4.6% | -9,000 (-0.45%) | View |
| 2021-02-12 5:01 pm Sale | 13G | CIDARA THERAPEUTICS INC CDTX | Stonepine Capital Management LLC | 0 0% | -2,054,048 (Position Closed) | View |
| 2021-02-12 4:17 pm Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | BB BIOTECH AG | 2,822,495 6.4% | 527,223 (+22.97%) | View |
| 2021-02-12 4:06 pm Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | BIOTECHNOLOGY VALUE FUND L P | 4,461,494 9.99% | 1,092,736 (+32.44%) | View |
| 2021-02-12 1:51 pm Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | Omega Fund V L.P. | 3,255,248 7.2% | 364,735 (+12.62%) | View |